Lung cancer has emerged as the most prevalent cancer globally, raising significant concerns among health experts.

Jonathan Thompson, MD, MS, highlighted that reducing delays in molecular testing and treatment initiation is critical for improving lung cancer outcomes, and that clinical trial data suggest ...

National registry study finds overall survival improved across the board after the introduction of immune checkpoint ...

Despite their considerable allure in the eyes of many as the solution to the climate crisis, nuclear reactors are not green.

New research reveals that GLP-1 receptor agonists significantly lower mortality risk in older cancer patients with type 2 ...

SHELTON, CONNECTICUT / ACCESS Newswire / August 18, 2025 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC ...